Nuclear Medicine in TMJ Imaging

  • Ingrid Różyło-Kalinowska


Nuclear medicine deals with diagnostics and therapy using radioactive isotopes emitting beta or gamma radiation. Radiopharmaceuticals are pharmaceuticals containing radioactive isotope as tracer and a ligand, i.e. a molecule, chemical compound or cell (e.g. granulocyte) that has an affinity towards a tissue or organ. When administered to a patient, radioactivity emitted by a radiopharmaceutical is being registered. As various tissues and organs differently accumulate this tracer, changes in radioisotope intake are detectable, especially when tissue metabolism rate is disturbed by a pathological process.

Registration of radiation can be performed by means of a single static gamma camera (also known as a scintillation camera), one or more rotating gamma cameras or multiheaded gamma cameras. Depending on the type of registration device, the imaging methods are divided into scintigraphy, single-photon emission computed tomography (SPECT) and positron emission tomography (PET).


Nuclear medicine Bone scintigraphy Single-photon emission computed tomography (SPECT) Positron emission tomography (PET) 


  1. 1.
    Choi BH, Yoon SH, Song SI, Yoon JK, Lee SJ, An YS. Comparison of diagnostic performance between visual and quantitative assessment of bone scintigraphy results in patients with painful temporomandibular disorder. Medicine (Baltimore). 2016;95(2):e2485. Scholar
  2. 2.
    Lee JW, Lee SM, Kim SJ, Choi JW, Baek KW. Clinical utility of fluoride-18 positron emission tomography/CT in temporomandibular disorder with osteoarthritis: comparisons with 99mTc-MDP bone scan. Dentomaxillofac Radiol. 2013;42(2):29292350. Scholar
  3. 3.
    Suh MS, Lee WW, Kim Y-K, Yun P-Y, Kim SE. Maximum standardized uptake value of 99mTc hydroxymethylene diphosphonate SPECT/CT for the evaluation of temporomandibular joint disorder. Radiology. 2016;280(3):890–6.CrossRefGoogle Scholar
  4. 4.
    Epstein JB, Rea A, Chahal O. The use of bone scintigraphy in temporomandibular joint disorders. Oral Dis. 2002;8(1):47–53.CrossRefGoogle Scholar
  5. 5.
    Hayashi D, Roemer FW, Katur A, Felson DT, Yang SO, Alomran F, Guermazi A. Imaging of synovitis in osteoarthritis: current status and outlook. Semin Arthritis Rheum. 2011;41(2):116–30.CrossRefGoogle Scholar
  6. 6.
    Kim JH, Kim YK, Kim SG, Yun PY, Kim JD, Min JH. Effectiveness of bone scans in the diagnosis of osteoarthritis of the temporomandibular joint. Dentomaxillofac Radiol. 2012;41(3):224–9.PubMedCentralCrossRefGoogle Scholar
  7. 7.
    Park KS, Song HC, Cho SG, Kang SR, Kim J, Jun HM, Song M, Jeong GC, Park HJ, Kwon SY, Min JJ, Bom HH. Open-mouth bone scintigraphy is better than closed-mouth bone scintigraphy in the diagnosis of temporomandibular osteoarthritis. Nucl Med Mol Imaging. 2016;50(3):213–8.PubMedCentralCrossRefGoogle Scholar
  8. 8.
    de Bois MH, Tak PP, Arndt JW, Kluin PM, Pauwels EK, Breedveld FC. Joint scintigraphy for quantification of synovitis with 99mTc-labelled human immunoglobulin G compared to histological examination. Clin Exp Rheumatol. 1995;13(2):155–9.Google Scholar
  9. 9.
    Martin-Granizo R, Garcia-Rielo JM, De la Sen O, Maniegas L, Berguer A, De Pedro M. Correlation between single photon emission computed tomography and histopathologic findings in condylar hyperplasia of the temporomandibular joint. J Craniomaxillofac Surg. 2017;45(6):839–44.CrossRefGoogle Scholar
  10. 10.
    Portelli M, Gatto E, Matarese G, Militi A, Catalfamo L, Gherlone E, Lucchese A. Unilateral condylar hyperplasia: diagnosis, clinical aspects and operative treatment. A case report. Eur J Paediatr Dent. 2015;16(2):99–102.Google Scholar
  11. 11.
    Rushinek H, Tabib R, Fleissig Y, Klein M, Tshori S. Evaluation of three analysis methods for 99mTc MDP SPECT scintigraphy in the diagnosis of unilateral condylar hyperplasia. Int J Oral Maxillofac Surg. 2016;45(12):1607–13.CrossRefGoogle Scholar
  12. 12.
    Ahn BC, Kim HJ, Lee SW, Yoo J, Choi JK, Lee J. New quantitative method for bone tracer uptake of temporomandibular joint using Tc-99m MDP skull SPECT. Ann Nucl Med. 2009;23(7):651–6.CrossRefGoogle Scholar
  13. 13.
    Suh MS, Park SH, Kim YK, Yun PY, Lee WW. 18F-NaF PET/CT for the evaluation of temporomandibular joint disorder. Clin Radiol. 2018;73(4):414.e7–414.e13. pii: S0009-9260(17)30527-5. Scholar
  14. 14.
    Güner DD, Oztürk Y, Sayman HB. Evaluation of the effects of functional orthopaedic treatment on temporomandibular joints with single-photon emission computerized tomography. Eur J Orthod. 2003;25(1):9–12.CrossRefGoogle Scholar
  15. 15.
    Hersek N, Canay S, Caner B, Ulutuncel N. Bone SPECT imaging of patients with internal derangement of temporomandibular joint before and after splint therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94(5):576–80.CrossRefGoogle Scholar
  16. 16.
    Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54.PubMedCentralCrossRefGoogle Scholar
  17. 17.
    Hu Y, Kuang B, Chen Y, Shu J. Imaging features for diffuse-type tenosynovial giant cell tumor of the temporomandibular joint: a case report. Medicine (Baltimore). 2017;96(26):e7383. Scholar
  18. 18.
    Shintaku WH, Venturin JS, Yepes JF. Application of advanced imaging modalities for the diagnosis of metastatic adenocarcinoma of the lungs in the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(6):e37–41. Scholar
  19. 19.
    Shintaku WH, Venturin JS, Langlais RP, Clark GT. Imaging modalities to access bony tumors and hyperplasic reactions of the temporomandibular joint. J Oral Surg. 2010;68(8):1911–21.Google Scholar
  20. 20.
    Terzic A, Becker M, Wissmeyer M, Scolozzi P. 18F-DOPA PET/CT unravels malignant paraganglioma mimicking temporomandibular joint disorder. Dentomaxillofac Radiol. 2011;40(5):315–9.PubMedCentralCrossRefGoogle Scholar
  21. 21.
    Rice DD, Abramovitch K, Roche S, Cora CA, Torralba KD, Christensen HL, Christiansen EL. Undiagnosed, chronic temporomandibular joint pain: making a case for FDG-PET/CT. Int J Rheum Dis. 2017;20(12):2122–6.CrossRefGoogle Scholar
  22. 22.
    Lindell B, Thor A. A case of glenoid fossa fracture, progressive ankylosis, total joint reconstruction with alloplastic prosthesis to normalized function including evaluation with F18-PET/CT-a four year follow-up. Craniomaxillofac Trauma Reconstr. 2017;10(1):60–5.CrossRefGoogle Scholar
  23. 23.
    Saridin CP, Raijmakers PG, Kloet RW, Tuinzing DB, Becking AG, Lammertsma AA. No signs of metabolic hyperactivity in patients with unilateral condylar hyperactivity: an in vivo positron emission tomography study. J Oral Maxillofac Surg. 2009;67(3):576–81.CrossRefGoogle Scholar
  24. 24.
    Bural GG, Laymon CM, Mountz JM. Nuclear imaging of a pregnant patient: should we perform nuclear medicine procedures during pregnancy? Mol Imaging Radionucl Ther. 2012;21(1):1–5.PubMedCentralCrossRefGoogle Scholar
  25. 25.
    Kaushik A, Jaimini A, Tripathi M, D’Souza M, Sharma R, Mondal A, Mishra AK, Dwarakanath BS. Estimation of radiation dose to patients from 18FDG whole body PET/CT investigations using dynamic PET scan protocol. Indian J Med Res. 2015;142(6):721–31.PubMedCentralCrossRefGoogle Scholar
  26. 26.
    Takalkar AM, Khandelwal A, Lokitz S, Lilien DL, Stabin MG. 18F-FDG PET in pregnancy and fetal radiation dose estimates. J Nucl Med. 2011;52(7):1035–40.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Ingrid Różyło-Kalinowska
    • 1
  1. 1.Independent Unit of Propaedeutics of Dentomaxillofacial RadiologyMedical University of LublinLublinPoland

Personalised recommendations